PTC Therapeutics, Inc. (PTCT): Price and Financial Metrics

PTC Therapeutics, Inc. (PTCT)

Today's Latest Price: $45.43 USD

1.28 (2.90%)

Updated Apr 9 8:00pm

Add PTCT to Watchlist
Sign Up

Overall POWR Rating

POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank

Industry Rank:

Ranked of 336 in Biotech

See all "A" rated Strong Buy stocks

PTCT Stock Summary

  • With a price/sales ratio of 8.68, Ptc Therapeutics Inc has a higher such ratio than 90.49% of stocks in our set.
  • With a year-over-year growth in debt of 105.12%, Ptc Therapeutics Inc's debt growth rate surpasses 86.48% of about US stocks.
  • Over the past twelve months, PTCT has reported earnings growth of 96.82%, putting it ahead of 88.79% of US stocks in our set.
  • Stocks with similar financial metrics, market capitalization, and price volatility to Ptc Therapeutics Inc are RTRX, RMBS, KPTI, SRPT, and XPL.
  • Visit PTCT's SEC page to see the company's official filings. To visit the company's web site, go to
PTCT Daily Price Range
PTCT 52-Week Price Range

PTCT Stock Price Chart More Charts

PTCT Price/Volume Stats

Current price $45.43 52-week high $59.89
Prev. close $44.15 52-week low $30.79
Day low $44.28 Volume 694,100
Day high $47.81 Avg. volume 970,872
50-day MA $49.12 Dividend yield N/A
200-day MA $45.33 Market Cap 2.85B

PTC Therapeutics, Inc. (PTCT) Company Bio

PTC Therapeutics is a global biopharmaceutical company focused on the discovery, development and commercialization of orally administered, proprietary small molecule drugs targeting an area of RNA biology we refer to as post-transcriptional control. The company was founded in 1998 and is based in South Plainfield, New Jersey.

PTCT Latest News Stream

Event/TimeNews Detail
Loading, please wait...

PTCT Latest Social Stream

Loading social stream, please wait...

View Full PTCT Social Stream

PTCT Price Returns

1-mo -3.50%
3-mo -10.06%
6-mo 28.73%
1-year 17.69%
3-year 335.99%
5-year -36.60%
YTD -5.41%
2019 39.95%
2018 105.76%
2017 52.89%
2016 -66.33%
2015 -37.42%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!

Page generated in 0.7565 seconds.